ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

ASCO Guidelines On CSFs Call For Use In Fewer Patients

December 2, 1994

Clinical Trials: Breast Cancer Prevention Trial requires Fewer Participants, NCI Says

September 6, 1996

Senate Appropriations Report Language On NCI, NIH Budgets

September 20, 1996

In Brief: Subcommittee Okays $980 Million for NCI In 1983, House Passes Waxman Bill, With Centers Line Item

October 8, 1982

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

Montefore Oncology Dept. Writes In Support of Peter Wiernik

November 12, 1993